Medicines and Allied Substances [No. of 2013 31 trial certificate if— (a) the application meets the requirements of this Act; (b) the clinical trial does not contravene any other written law; (c) appropriately qualified persons are available to handle the medicine or allied substance for purposes of the clinical trial; and (d) the premises on which the applicant proposes to conduct the clinical trials are suitable for the intended purpose. (2) A certificate granted under this section shall be valid for such period as shall be specified in the certificate. Grant of clinical trial certificate 52. The Authority shall inspect clinical trial sites during the course of the trial and at such intervals as it may determine. 53. (1) The Authority shall keep and maintain a Register of Clinical Trial Certificates issued under this Act in which it shall enter the names and other details relating to clinical trials. (2) The Register referred to in subsection (1) shall be kept at the offices of the Authority and shall be open to inspection by the public at such times and on such conditions, including the payment of a fee for inspection, as the Board may determine. Inspection of clinical trial sites Register of Clinical Trial Certificates PART VII THE NATIONAL DRUG QUALITY CONTROL LABORATORY 54. (1) There is hereby established the National Drug Quality Control Laboratory which shall be managed by the Authority and shall facilitate the regulation of medicines and allied substances under this Act. (2) The Authority shall use the Laboratory to— (a) verify the safety, quality and efficacy of medicines and allied substances which are manufactured or imported into the country by persons who are authorised or licenced under this Act; (b) examine, analyse and conduct research on medicine and allied substances; (c) provide laboratory services to the general public; (d) provide practical training for personnel in the analysis of medicines and allied substances; and (e) perform such other functions relating to the analysis of medicines and allied substances as it considers necessary. (3) The Authority shall charge such fees for the analysis of medicines and services provided by the Laboratory as it may National Drug Quality Control Laboratory